Manulife (Manufacturers Life Insurance)’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $54.9K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $30.5K | Sell |
|
|||||
|
2024
Q4 | $52.3K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $77.2K | Buy |
|
|||||
|
2024
Q1 | $91.4K | Buy |
|
|||||
|
2023
Q4 | $126K | Hold |
|
|||||
|
2023
Q3 | $142K | Buy |
|
|||||
|
2023
Q2 | $138K | Buy |
|
|||||
|
2023
Q1 | $201K | Hold |
|
|||||
|
2022
Q4 | $232K | Sell |
|
|||||
|
2022
Q3 | $283K | Sell |
|
|||||
|
2022
Q2 | $219K | Buy |
|
|||||
|
2022
Q1 | $351K | Sell |
|
|||||
|
2021
Q4 | $535 | Sell |
|
|||||
|
2021
Q3 | $549K | Sell |
|
|||||
|
2021
Q2 | $511K | Buy |
|
|||||
|
2021
Q1 | $496K | Sell |
|
|||||
|
2020
Q4 | $606K | Buy |
|
|||||
|
2020
Q3 | $623K | Sell |
|
|||||
|
2020
Q2 | $600K | Sell |
|
|||||
|
2020
Q1 | $649K | Buy |
|
|||||
|
2019
Q4 | $669K | Sell |
|
|||||
|
2019
Q3 | $786K | Sell |
|
|||||
|
2019
Q2 | $852K | Buy |
|
|||||
|
2019
Q1 | $471K | Buy |
|
|||||
|
2018
Q4 | $293K | Sell |
|
|||||
|
2018
Q3 | $569K | Sell |
|
|||||
|
2018
Q2 | $505K | Buy |
|
|||||
|
2018
Q1 | $347K | Sell |
|
|||||
|
2017
Q4 | $276K | Buy |
|
|||||
|
2017
Q3 | $409K | Buy |
|
|||||
|
2017
Q2 | $436K | Buy |
|
|||||
|
2017
Q1 | $509K | Buy |
|
|||||
|
2016
Q4 | $578K | Sell |
|
|||||
|
2016
Q3 | $553K | Sell |
|
|||||
|
2016
Q2 | $351K | Buy |
|
|||||
|
2016
Q1 | $314K | Buy |
|
|||||
|
2015
Q4 | $370 | Buy |
|
|||||
|
2015
Q3 | $320 | Buy |
|
|||||
|
2015
Q2 | $452 | Buy |
|
|||||
|
2015
Q1 | $136 | Buy |
|